Profile of acotiamide in the treatment of functional dyspepsia

Masahiro Ueda, Eisuke Iwasaki, Hidekazu Suzuki

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Efficacy of acotiamide for improving symptoms in patients with functional dyspepsia was shown by several clinical trials. In a randomized, double-blind, placebo-controlled, parallel-group comparative Phase III trial conducted in Japan, 100 mg of acotiamide three times a day for 4 weeks was more effective than a placebo for improving symptoms, and quality of life. Acotiamide was well-tolerated treatment, with no significant adverse events. The aim of this review was to summarize the current evidence of the efficacy of acotiamide in the treatment of patients with functional dyspepsia.

Original languageEnglish
Pages (from-to)83-88
Number of pages6
JournalClinical and Experimental Gastroenterology
Volume9
DOIs
Publication statusPublished - 2016 Apr 6

Fingerprint

Dyspepsia
Placebos
Therapeutics
Japan
Quality of Life
Clinical Trials
Z 338

Keywords

  • Acetylcholinesterase
  • Acotiamide
  • Functional dyspepsia
  • Rome III

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Profile of acotiamide in the treatment of functional dyspepsia. / Ueda, Masahiro; Iwasaki, Eisuke; Suzuki, Hidekazu.

In: Clinical and Experimental Gastroenterology, Vol. 9, 06.04.2016, p. 83-88.

Research output: Contribution to journalArticle

@article{1ba940701d12444ea5427955f180b0e0,
title = "Profile of acotiamide in the treatment of functional dyspepsia",
abstract = "Efficacy of acotiamide for improving symptoms in patients with functional dyspepsia was shown by several clinical trials. In a randomized, double-blind, placebo-controlled, parallel-group comparative Phase III trial conducted in Japan, 100 mg of acotiamide three times a day for 4 weeks was more effective than a placebo for improving symptoms, and quality of life. Acotiamide was well-tolerated treatment, with no significant adverse events. The aim of this review was to summarize the current evidence of the efficacy of acotiamide in the treatment of patients with functional dyspepsia.",
keywords = "Acetylcholinesterase, Acotiamide, Functional dyspepsia, Rome III",
author = "Masahiro Ueda and Eisuke Iwasaki and Hidekazu Suzuki",
year = "2016",
month = "4",
day = "6",
doi = "10.2147/CEG.S72172",
language = "English",
volume = "9",
pages = "83--88",
journal = "Clinical and Experimental Gastroenterology",
issn = "1178-7023",
publisher = "Dove Medical Press Ltd.",

}

TY - JOUR

T1 - Profile of acotiamide in the treatment of functional dyspepsia

AU - Ueda, Masahiro

AU - Iwasaki, Eisuke

AU - Suzuki, Hidekazu

PY - 2016/4/6

Y1 - 2016/4/6

N2 - Efficacy of acotiamide for improving symptoms in patients with functional dyspepsia was shown by several clinical trials. In a randomized, double-blind, placebo-controlled, parallel-group comparative Phase III trial conducted in Japan, 100 mg of acotiamide three times a day for 4 weeks was more effective than a placebo for improving symptoms, and quality of life. Acotiamide was well-tolerated treatment, with no significant adverse events. The aim of this review was to summarize the current evidence of the efficacy of acotiamide in the treatment of patients with functional dyspepsia.

AB - Efficacy of acotiamide for improving symptoms in patients with functional dyspepsia was shown by several clinical trials. In a randomized, double-blind, placebo-controlled, parallel-group comparative Phase III trial conducted in Japan, 100 mg of acotiamide three times a day for 4 weeks was more effective than a placebo for improving symptoms, and quality of life. Acotiamide was well-tolerated treatment, with no significant adverse events. The aim of this review was to summarize the current evidence of the efficacy of acotiamide in the treatment of patients with functional dyspepsia.

KW - Acetylcholinesterase

KW - Acotiamide

KW - Functional dyspepsia

KW - Rome III

UR - http://www.scopus.com/inward/record.url?scp=84962684467&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962684467&partnerID=8YFLogxK

U2 - 10.2147/CEG.S72172

DO - 10.2147/CEG.S72172

M3 - Article

AN - SCOPUS:84962684467

VL - 9

SP - 83

EP - 88

JO - Clinical and Experimental Gastroenterology

JF - Clinical and Experimental Gastroenterology

SN - 1178-7023

ER -